Relative risk of developing myelodysplastic syndrome in patients with aplastic anemia by multivariate analysis
| Variable . | Relative risk (95% CI) . | P . |
|---|---|---|
| No. of days of G-CSF therapy5-150 | 1.003 (1.001-1.003) | .001 |
| No response to therapy at 6 mo | 3.46 (1.10-10.9) | .03 |
| Variable . | Relative risk (95% CI) . | P . |
|---|---|---|
| No. of days of G-CSF therapy5-150 | 1.003 (1.001-1.003) | .001 |
| No response to therapy at 6 mo | 3.46 (1.10-10.9) | .03 |
CI indicates confidence interval; G-CSF, granulocyte colony-stimulating factor.
As a continuous variable.